• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Santen Pharm CO ADR (OP:SNPHY)

    11.68 -0.58 (-4.73%)
    Streaming Delayed Price Updated: 11:12 AM EDT, Aug 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Santen Pharm CO ADR

    News headline image
    Santen Joins Inaugural Global Summit for Eye Health as High-Impact Partner
    From Santen Pharmaceutical Co., Ltd.
    Via JCN Newswire
    News headline image
    SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023 ↗
    Santen Pharmaceutical just reported results for the fourth quarter of 2023. 
    Via InvestorPlace
    News headline image
    Current Analysis: Santen Pharmaceutical ↗
    Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. Over the past year, Santen's share price rose about 32% from $7.60 to $10.01 as of Thursday’s market... 
    Via Talk Markets
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.